Your browser is no longer supported. Please, upgrade your browser.
Settings
CRL Charles River Laboratories International, Inc. daily Stock Chart
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E22.91 EPS (ttm)2.95 Insider Own1.40% Shs Outstand46.78M Perf Week-3.59%
Market Cap3.16B Forward P/E16.51 EPS next Y4.09 Insider Trans-7.66% Shs Float45.96M Perf Month-11.30%
Income140.10M PEG2.42 EPS next Q0.94 Inst Own- Short Float3.51% Perf Quarter-7.66%
Sales1.32B P/S2.40 EPS this Y25.60% Inst Trans-0.32% Short Ratio3.79 Perf Half Y-11.96%
Book/sh15.03 P/B4.50 EPS next Y12.57% ROA7.50% Target Price77.77 Perf Year10.44%
Cash/sh3.61 P/C18.72 EPS next 5Y9.49% ROE20.60% 52W Range55.47 - 84.69 Perf YTD6.21%
Dividend- P/FCF15.65 EPS past 5Y9.40% ROI9.00% 52W High-20.19% Beta1.43
Dividend %- Quick Ratio2.00 Sales past 5Y2.10% Gross Margin37.30% 52W Low21.85% ATR2.53
Employees7900 Current Ratio2.30 Sales Q/Q-0.50% Oper. Margin15.50% RSI (14)40.93 Volatility2.64% 3.26%
OptionableYes Debt/Eq1.10 EPS Q/Q36.00% Profit Margin10.60% Rel Volume0.54 Prev Close67.95
ShortableYes LT Debt/Eq1.08 EarningsJul 30 BMO Payout0.00% Avg Volume425.12K Price67.59
Recom2.70 SMA20-5.90% SMA50-7.43% SMA200-6.33% Volume231,345 Change-0.53%
Jul-31-15Reiterated Deutsche Bank Hold $76 → $79
Jul-10-15Upgrade BofA/Merrill Neutral → Buy $76 → $83
Jul-10-15Downgrade Barclays Equal Weight → Underweight $60
May-04-15Upgrade Sun Trust Rbsn Humphrey Neutral → Buy $88
Apr-24-15Reiterated Barclays Equal Weight $55 → $60
Feb-12-15Reiterated Deutsche Bank Hold $63 → $77
Feb-13-14Reiterated Barclays Equal Weight $41 → $55
Nov-21-13Initiated Deutsche Bank Hold $55
Sep-17-13Initiated UBS Neutral $49
Jun-03-13Reiterated Barclays Equal Weight $38 → $41
May-02-13Reiterated ISI Group Neutral $45.50 → $44.50
Feb-14-13Reiterated ISI Group Neutral $40.50 → $43
Jul-14-11Initiated BB&T Capital Mkts Buy $47
May-05-11Reiterated UBS Neutral $40 → $42
Jan-06-11Downgrade Deutsche Bank Buy → Hold $37 → $37
May-12-10Upgrade Robert W. Baird Neutral → Outperform $37
Jan-07-10Upgrade Deutsche Bank Hold → Buy $38.50 → $39
Nov-09-09Downgrade Barclays Capital Overweight → Equal Weight
May-13-09Initiated Deutsche Securities Hold
Apr-20-09Downgrade Jefferies & Co Buy → Hold $33
Sep-03-15 09:25AM  BioTelemetry (BEAT) Worth Watching: Stock Rises 6.7%
Aug-28-15 01:55PM  Charles River Laboratories International, Inc. Earnings Q2, 2015
Aug-18-15 04:45PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Aug-16-15 09:10AM  Credit Suisse Sees Big Biopharma Upside in Top Contract Research Outfits at 24/7 Wall St.
Aug-12-15 06:00AM  Jim Cramer's Top Takeaways: WisdomTree Investments, Google, Charles River Labs at TheStreet
Aug-11-15 08:08PM  Jim Cramer's 'Mad Money' Recap: How to Make Sense of China's Desperate Act at TheStreet
Aug-10-15 09:30AM  Zacks Investment Ideas feature highlights: INC Research, AMN Healthcare Services, Charles River Associates, Envision Healthcare and Express Scripts - Press Releases
Aug-06-15 01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials
Aug-05-15 08:53AM  How Charles River Laboratories International (CRL) Stock Stands Out in a Strong Industry - Tale of the Tape
Aug-04-15 10:40AM  Intertek Group Plc: Strong price momentum but will it sustain?
Aug-01-15 08:09PM  10-Q for Charles River Laboratories International, Inc. at Company Spotlight
Jul-30-15 04:21PM  Edited Transcript of CRL earnings conference call or presentation 30-Jul-15 12:30pm GMT
09:06AM  McKesson (MCK) Tops Q1 Earnings, Ups Fiscal '16 Outlook - Analyst Blog
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
08:13AM  Charles River misses 2Q profit forecasts
07:15AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:07AM  Q2 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:01AM  Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement Business Wire
07:00AM  Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations Business Wire
Jul-24-15 04:05PM  Charles River Laboratories Completes the Acquisition of Celsis International Ltd. Business Wire
Jul-21-15 02:15PM  Its earnings season: Here are 9 local biotech firms that are actually making a profit at bizjournals.com
Jul-17-15 09:05AM  Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks at 24/7 Wall St.
Jul-10-15 12:21PM  Charles River Laboratories (CRL) Stock Downgraded at Barclays at TheStreet
08:15AM  Analysts' Actions -- Ameriprise, Costco, Nokia and More
08:11AM  Barclays Cuts Charles River Labs, Sees Lack Of Demand Proof Over Long-Term
08:05AM  Charles River upgraded by BofA/Merrill
Jul-09-15 08:25PM  Carl Announces Completion of Private Placement Marketwired
02:01PM  Why Charles River Labs spent $212M on a bacteria detection company at bizjournals.com
07:00AM  Charles River Laboratories to Acquire Celsis International Ltd. Business Wire
Jul-07-15 09:09PM  Carl Announces Private Placement Marketwired
04:15PM  Charles River Laboratories Schedules Second-Quarter 2015 Earnings Release and Conference Call Business Wire
07:00AM  4 Stocks Rising on Unusual Volume at TheStreet
Jun-18-15 09:00AM  Carl Subsidary Signs Data Services Agreement With RA Revenue Automation Marketwired
Jun-02-15 09:10AM  Analyst Offers Top US Growth Stock Calls for This Week at 24/7 Wall St.
Jun-01-15 08:00AM  Charles River Laboratories to Present at Jefferies Conference Business Wire
May-27-15 11:59AM  Jefferies Boosts Targets Across Pharmaceutical Service Stocks
May-26-15 09:00AM  Carl Appoints Industry Expert Bryan Segal to the Board of Directors Marketwired
May-11-15 11:50AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-04-15 08:12PM  10-Q for Charles River Laboratories International, Inc. at Company Spotlight
04:54PM  Charles River Laboratories to Present at Baird and Deutsche Bank Conferences at noodls
04:30PM  Charles River Laboratories to Present at Baird and Deutsche Bank Conferences Business Wire
Apr-30-15 09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today -9.30%
06:10AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
Apr-29-15 05:17PM  Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations at noodls
04:39PM  Charles River misses Street 1Q forecasts
04:30PM  Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations Business Wire
07:07AM  Q1 2015 Charles River Laboratories International Inc Earnings Release - After Market Close
Apr-27-15 06:03PM  Charles River Laboratories Int'l, Inc. -- Moody's affirms Charles River's Ba2 CFR; changes outlook to positive at Moody's
09:02AM  Jefferies Previews Booming Biotech Earnings
Apr-22-15 04:31PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obli
Apr-16-15 09:00AM  Carl Enters Into Letter of Intent for the Purchase of FlowWorks Inc. Marketwired
Apr-09-15 09:32AM  Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call at noodls
09:00AM  Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call Business Wire
Mar-26-15 08:25AM  Top Analyst Upgrades and Downgrades: Apple, ASML, Schwab, GoPro, Kraft, Netflix, Red Hat and More at 24/7 Wall St.
Mar-11-15 04:06PM  Teachers adds a new stake in PRA Health Sciences
Mar-09-15 07:31PM  Charles River Laboratories to Present at March Investor Conferences at noodls
Mar-02-15 08:00AM  Charles River Laboratories to Present at March Investor Conferences Business Wire
Feb-27-15 05:36PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb-26-15 09:00AM  Carl Appoints New President, Chief Executive Officer Marketwired
Feb-25-15 05:03PM  CFO Moves: Charles River Laboratories International, PrairieSky Royalty, SuperGroup at The Wall Street Journal
Feb-24-15 05:06PM  Charles River Laboratories Announces Planned Management Changes at noodls
04:30PM  Charles River Laboratories Announces Planned Management Changes Business Wire
Feb-19-15 07:07PM  10-K for Charles River Laboratories International, Inc. Company Spotlight
Feb-17-15 03:32PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-11-15 06:00PM  Cramer shifts his attention overseas CNBC
04:15PM  Charles River Laboratories to Present at Leerink Global Healthcare Conference Business Wire
09:54AM  Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog Zacks
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
06:02AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
Feb-10-15 04:48PM  Charles River tops Street 4Q forecasts AP
04:30PM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance Business Wire
07:07AM  Q4 2014 Charles River Laboratories International Inc Earnings Release - After Market Close CCBN
Feb-05-15 09:00AM  Carl Subsidiary Hires Chief Technology Officer Marketwired
Jan-26-15 04:15PM  Charles River Laboratories Schedules Fourth-Quarter 2014 Earnings and 2015 Guidance Release and Conference Call Business Wire
Jan-15-15 02:35PM  Quintiles chief looks to grab market share with LabCorp-Covance deal at American City Business Journals
06:00AM  Jim Cramer's Top Stock Picks: MNST ESPR CRL at TheStreet
Jan-14-15 08:22PM  Jim Cramer's 'Mad Money' Recap: Will You Still Hate the Markets Tomorrow? at TheStreet
07:10PM  Cramer Remix: Coke, Pepsi or Monster? at CNBC
Jan-12-15 08:00AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Dec-11-14 07:38AM  Cancer Genetics (CGIX) Looks Good: Stock Rises 8% Zacks
Dec-02-14 09:21AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in EDGAR Online
Nov-12-14 07:57AM  Intrexon (XON) Looks Good: Stock Moves 11% Higher Zacks
Nov-10-14 04:42PM  How Much to End a Marriage? Almost $1 Billion For Harold Hamm at Barrons.com
Nov-04-14 06:03AM  Strength Seen in Covance (CVD): Stock Surges 25.9% Zacks
Nov-03-14 11:00AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Nov-01-14 08:07PM  10-Q for Charles River Laboratories International, Inc. Company Spotlight
Oct-30-14 08:11PM  Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong at TheStreet
07:49PM  Cramer Remix: Apologies owed on Wall Street at CNBC
02:52PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
11:30AM  Charles River (CRL) Beats on Q3 Earnings, Guidance Upped Zacks
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
Oct-29-14 06:45PM  Charles River beats Street 3Q forecasts AP
04:42PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
04:05PM  Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing Operations Business Wire
02:15PM  Express Scripts Reports In-Line Q3 Earnings, Narrows View Zacks
11:00AM  McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance Zacks
07:07AM  Q3 2014 Charles River Laboratories International Inc Earnings Release - After Market Close CCBN
Oct-28-14 07:16AM  Why Earnings Season Could Be Great for Charles River Laboratories International (CRL) Zacks
Oct-27-14 11:40AM  Omnicare Beats on Q3 Earnings and Sales, Outlook Positive Zacks
Oct-24-14 09:10AM  Healthways Earnings and Revenues in Line, View Maintained Zacks
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist its clients in supporting the use of research models in drug discovery and development comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target within a cell through delivery of clinical drug candidates; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides non-animal or in vitro methods for lot release testing of medical devices and injectable drugs for endotoxin contamination. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and specific pathogen free fertile chicken eggs and chickens for the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ACKERMAN THOMAS FSenior Financial AdvisorAug 17Option Exercise37.925,000189,600105,635Aug 18 02:09 PM
ACKERMAN THOMAS FSenior Financial AdvisorAug 17Sale75.535,000377,665100,635Aug 18 02:09 PM
Kochevar Deborah TurnerDirectorAug 03Option Exercise52.293,530184,58414,270Aug 05 08:57 AM
Kochevar Deborah TurnerDirectorAug 03Sale76.696,250479,3048,020Aug 05 08:57 AM
CHUBB STEPHEN DDirectorAug 03Sale76.462,000152,92715,504Aug 05 07:31 AM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Option Exercise37.925,000189,600105,635May 18 04:11 PM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Sale71.061,10078,168100,635May 18 04:13 PM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Sale70.513,900274,974101,735May 18 04:11 PM
MASSARO GEORGEDirectorMay 07Sale70.211,36095,48715,120May 08 07:26 AM
CHUBB STEPHEN DDirectorMay 01Sale69.802,000139,59515,534May 05 04:48 PM
Crowley John JSVP, Chief Accounting OfficerMar 04Option Exercise59.4191254,1826,131Mar 06 12:50 PM
Crowley John JSVP, Chief Accounting OfficerMar 04Sale76.5391269,7925,219Mar 06 12:50 PM
CHUBB STEPHEN DDirectorMar 03Sale75.522,000151,04717,854Mar 05 08:17 AM
FOSTER JAMES CChairman, President and CEOMar 02Option Exercise59.4120,0711,192,418360,333Mar 04 06:34 AM
GILLETT NANCYCorporate Executive VPMar 02Option Exercise59.414,379260,15622,589Mar 03 02:42 PM
Kochevar Deborah TurnerDirectorMar 02Sale76.592,600199,1378,770Mar 03 02:59 PM
GILLETT NANCYCorporate Executive VPMar 02Sale76.724,379335,94918,210Mar 03 02:42 PM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.932,036156,625340,262Mar 04 06:39 AM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.679,483727,051342,298Mar 04 06:36 AM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.488,552654,091351,781Mar 04 06:34 AM
GILLETT NANCYCorporate Executive VPFeb 27Sale76.952,772213,30619,162Mar 03 11:31 AM
GELLER JORGCorporate Executive VPFeb 25Option Exercise37.032,863106,01717,820Feb 27 09:33 AM
GILLETT NANCYCorporate Executive VPFeb 25Option Exercise37.8417,477661,39639,411Feb 27 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 25Option Exercise37.0335,5381,315,972360,083Feb 27 09:41 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.273,532269,39922,805Feb 26 12:06 PM
GELLER JORGCorporate Executive VPFeb 25Sale76.793,726286,12614,094Feb 27 09:33 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.8611,003845,683324,545Feb 27 09:53 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.7112,914990,641335,548Feb 27 09:51 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.457,000535,142348,462Feb 27 09:44 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale75.964,621351,029355,462Feb 27 09:41 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.8011,477881,47621,934Feb 27 09:57 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.596,000459,53833,411Feb 27 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise36.2524,387884,029364,482Feb 25 05:24 PM
GELLER JORGCorporate Executive VPFeb 24Option Exercise36.256,987253,27928,319Feb 25 09:34 PM
GILLETT NANCYCorporate Executive VPFeb 24Sale75.741,483112,32727,969Feb 26 12:06 PM
GELLER JORGCorporate Executive VPFeb 24Sale76.301,30199,26014,957Feb 25 09:39 PM
GELLER JORGCorporate Executive VPFeb 24Sale76.1712,061918,65615,558Feb 25 09:34 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale76.2212,433947,582342,178Feb 25 05:28 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale76.402,083159,145340,095Feb 25 05:29 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale75.704,800363,364359,682Feb 25 05:24 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale75.965,071385,217354,611Feb 25 05:26 PM
FOSTER JAMES CChairman, President and CEOFeb 23Option Exercise40.4021,779879,872361,874Feb 25 09:23 AM
GELLER JORGCorporate Executive VPFeb 23Option Exercise40.405,502222,28128,373Feb 24 02:22 PM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.973,400261,684340,095Feb 25 09:29 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.769,956764,174343,495Feb 25 09:26 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.568,423644,829353,451Feb 25 09:23 AM
GELLER JORGCorporate Executive VPFeb 23Sale76.597,041539,29121,332Feb 24 02:22 PM
MILNE GEORGE M JRDirectorFeb 20Option Exercise61.726,000370,32036,790Feb 23 01:00 PM
FOSTER JAMES CChairman, President and CEOFeb 20Option Exercise58.5870,2294,114,015413,193Feb 24 04:01 PM
FOSTER JAMES CChairman, President and CEOFeb 20Sale75.0070,2295,267,175342,964Feb 24 04:01 PM
MILNE GEORGE M JRDirectorFeb 20Sale75.876,000455,22330,790Feb 23 01:00 PM
FOSTER JAMES CChairman, President and CEOFeb 19Option Exercise58.589,671566,527352,635Feb 20 01:29 PM
FOSTER JAMES CChairman, President and CEOFeb 19Sale75.009,671725,325342,964Feb 20 01:29 PM
CHUBB STEPHEN DDirectorFeb 18Option Exercise61.726,000370,32024,865Feb 19 07:22 AM
CHUBB STEPHEN DDirectorFeb 18Sale73.975,011370,64919,854Feb 19 07:22 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Option Exercise36.925,000184,600109,211Feb 18 02:12 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Sale73.7560044,248104,211Feb 18 02:14 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Sale73.504,400323,398104,811Feb 18 02:12 PM
GELLER JORGCorporate Executive VPFeb 17Sale73.722,570189,46922,871Feb 18 01:11 PM
GELLER JORGCorporate Executive VPFeb 17Sale73.5414,4301,061,12025,441Feb 18 01:09 PM
Molho DavideCorporate Executive VPFeb 13Option Exercise36.252,40087,00045,704Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 13Sale74.0058243,068574Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 13Sale74.002,400177,60043,304Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Option Exercise36.258,675314,46951,979Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Sale74.007,418548,9321,156Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Sale74.008,675641,95043,304Feb 17 10:05 AM
GELLER JORGCorporate Executive VPFeb 12Sale73.688,458623,16339,871Feb 17 07:59 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOJan 26Option Exercise37.9210,000379,200114,211Jan 28 02:28 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJan 26Sale70.0010,000700,000104,211Jan 28 02:28 PM
JOHST DAVID PCorp Executive VPJan 08Option Exercise47.364,737224,344147,686Jan 12 07:18 AM
JOHST DAVID PCorp Executive VPJan 08Sale67.004,737317,379142,949Jan 12 07:18 AM
JOHST DAVID PCorp Executive VPJan 07Option Exercise58.5826,1001,528,938169,049Jan 08 11:16 AM
JOHST DAVID PCorp Executive VPJan 07Sale65.0026,1001,696,500142,949Jan 08 11:16 AM
CHUBB STEPHEN DDirectorDec 01Sale64.442,000128,88118,865Dec 02 02:44 PM
JOHST DAVID PCorp Executive VPNov 28Option Exercise47.366,982330,668149,931Dec 02 08:52 AM
JOHST DAVID PCorp Executive VPNov 28Sale65.346,982456,171142,949Dec 02 08:52 AM
GELLER JORGCorporate Executive VPNov 14Option Exercise58.587,350430,56355,679Nov 17 02:42 PM
GELLER JORGCorporate Executive VPNov 14Sale63.801,740111,01348,329Nov 17 02:44 PM
GELLER JORGCorporate Executive VPNov 14Sale63.575,610356,61950,069Nov 17 02:42 PM
Molho DavideCorporate Executive VPNov 12Option Exercise37.039,360346,60152,664Nov 14 03:14 PM
Molho DavideCorporate Executive VPNov 12Sale64.689,360605,37343,304Nov 14 03:14 PM
REESE C RICHARDDirectorNov 06Option Exercise61.726,000370,32028,790Nov 07 02:20 PM
REESE C RICHARDDirectorNov 06Sale63.395,849370,74322,941Nov 07 02:20 PM
Crowley John JSVP, Chief Accounting OfficerNov 04Option Exercise46.621,00046,6205,607Nov 05 02:37 PM
Crowley John JSVP, Chief Accounting OfficerNov 04Sale64.001,00064,0014,607Nov 05 02:37 PM
MASSARO GEORGEDirectorNov 03Option Exercise41.6716,710696,33226,220Nov 04 03:33 PM
GILLETT NANCYCorporate Executive VPNov 03Option Exercise58.5826,7311,565,90256,646Nov 05 12:19 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 03Option Exercise52.8636,1001,908,138140,311Nov 04 02:17 PM
Molho DavideCorporate Executive VPNov 03Option Exercise37.0316,402607,36659,706Nov 04 03:24 PM
Molho DavideCorporate Executive VPNov 03Sale64.5416,4021,058,54743,304Nov 04 03:24 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 03Sale65.0036,1002,346,500104,211Nov 04 02:17 PM
GILLETT NANCYCorporate Executive VPNov 03Sale64.9135,3312,293,16329,915Nov 05 12:19 PM
MASSARO GEORGEDirectorNov 03Sale65.0016,7101,086,15015,510Nov 04 03:33 PM
GILLETT NANCYCorporate Executive VPOct 30Option Exercise58.581,06962,62239,584Nov 03 10:47 AM
GILLETT NANCYCorporate Executive VPOct 30Sale65.001,06969,48538,515Nov 03 10:47 AM
JOHST DAVID PCorp Executive VPOct 28Option Exercise42.2574,7803,159,360217,729Oct 30 05:04 PM
JOHST DAVID PCorp Executive VPOct 28Sale64.0074,7804,785,920142,949Oct 30 05:04 PM
FOSTER JAMES CChairman, President and CEOOct 21Option Exercise47.7528,9971,384,607379,961Oct 22 01:26 PM
FOSTER JAMES CChairman, President and CEOOct 21Sale62.0028,9971,797,814350,964Oct 22 01:26 PM
FOSTER JAMES CChairman, President and CEOOct 03Option Exercise47.68136,6476,515,753487,611Oct 07 02:10 PM